TrialCPT: pharmacometrics & systems pharmacology2026

Pharmacokinetics of Odronextamab, A Bispecific T-Cell-Engaging Antibody, in Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma.

Marçal Bravo Padros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.